PFU rules that Finansavisen breached press ethics in coverage of Lifecare s market disclosures

30 Jan 2026 07:00 CET

Bergen, 30 January 2026 - Lifecare ASA notes that the Norwegian Press
Complaints Commission (PFU) has upheld the Company's complaint concerning
media coverage related to Lifecare's stock exchange announcements.

The complaint concerned an article series published in Finansavisen in late
August 2025, consisting of three articles online and three articles in print,
including front-page coverage in the printed edition.

Reviews conducted by the PFU and, subsequently, by the Norwegian Financial
Supervisory Authority (Finanstilsynet) following this media coverage highlight
the importance of responsible financial journalism and transparent market
communication for the protection of shareholder interests.

Following its review, the PFU concluded that the coverage breached fundamental
principles of good press practice, including the failure to clearly
distinguish between facts and commentary, the use of headlines not
sufficiently supported by the underlying content, and inadequate correction of
errors.

The PFU emphasised that editorial opinions were presented in a manner that
could reasonably be perceived by readers as factual information in news
reporting, thereby blurring the line between commentary and news. The
Commission further found that certain headlines and presentations went beyond
what was warranted by the factual basis of the articles, and that identified
errors were not rectified in a sufficiently clear and timely manner.

Following the same media coverage, the Norwegian Financial Supervisory
Authority (Finanstilsynet) contacted Lifecare in October 2025 to request
information in order to assess the Company's stock exchange announcements
related to its ongoing long-term study of wireless glucose monitoring.
Lifecare fully cooperated with the inquiry and provided comprehensive
documentation regarding the study, its status, and the Company's dialogue with
relevant authorities.

After reviewing the information submitted, Finanstilsynet decided in December
2025 to conclude its review without further action. In its closing remarks,
the Authority noted that "price movements were observed in connection with
these announcements," while at the same time determining that there was no
basis for continued supervisory follow-up.

Lifecare welcomes both the PFU's thorough consideration of the press-ethical
aspects of the media coverage and Finanstilsynet's review of the Company's
market communication in relation to the stock exchange announcements in
question. Taken together, these conclusions underscore that the announcements
formed a legitimate source of information for the market.

This case illustrates that the integrity of capital markets depends not only
on accurate disclosure from listed companies, but also on the manner in which
that information is interpreted and presented by financial media. Media
coverage that is later found to be in breach of press ethics may have a
material impact on share price development, particularly when editorial
opinions are presented as factual news in a financial context. Such coverage
can contribute to significant and rapid value erosion, which
disproportionately affects smaller, non-professional shareholders who rely on
accurate and balanced information when making investment decisions.

Lifecare recognises the essential role of a free, critical and independent
financial press in scrutinising listed companies and safeguarding market
transparency. That role, however, carries a corresponding responsibility to
ensure that commentary and opinion are clearly distinguished from factual
reporting, and that information presented as news is accurate, balanced and
properly contextualised. Confidence in both the media and the capital markets
depends on the adherence to established press-ethical standards, including
clear separation between fact and opinion, proportional presentation, and the
responsible handling of errors.

For the sake of transparency, Lifecare has made relevant documentation
available on its website, including the Company's complaint to the PFU and
subsequent submissions, as well as correspondence with Finanstilsynet,
Lifecare's response, and the Authority's concluding remarks. These materials
can be accessed at www.lifecare.no (http://www.lifecare.no/).

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

More information:
Access the news on Oslo Bors NewsWeb site

664496_PFU rules that Finansavisen breached press ethics in coverage of Lifecare s market disclosures.pdf
664496_PFUs Uttalelse Finansavisen Brøt God Presseskikk.pdf